Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Connect Biopharma Holdings Limited (NASDAQ: CNTB)
CNTB Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
154.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
285.70%
CNTB Stock Analysis
CNTB
PE Ratio:
CNTB
PEG Ratio:
Not Available
CNTB
Forward EPS Growth (12 month):
0.00%
CNTB
PS Ratio:
602.6
CNTB
PSG Ratio:
1.5
CNTB
Forward Revenue Growth (12 month):
400.00%
CNTB Articles
No data was found